(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic Acids as S1P1 Functional Antagonists

ACS Medicinal Chemistry Letters
2014.0

Abstract

S1P1 is a validated target for treatment of autoimmune disease, and functional antagonists with superior safety and pharmacokinetic properties are being sought as second generation therapeutics. We describe the discovery and optimization of (7-benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic acids as potent, centrally available, direct acting S1P1 functional antagonists, with favorable pharmacokinetic and safety properties.

Knowledge Graph

Similar Paper

(7-Benzyloxy-2,3-dihydro-1H-pyrrolo[1,2-a]indol-1-yl)acetic Acids as S1P<sub>1</sub> Functional Antagonists
ACS Medicinal Chemistry Letters 2014.0
Discovery of 3-arylpropionic acids as potent agonists of sphingosine-1-phosphate receptor-1 (S1P1) with high selectivity against all other known S1P receptor subtypes
Bioorganic &amp; Medicinal Chemistry Letters 2006.0
Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor
ACS Medicinal Chemistry Letters 2014.0
Discovery and Structure–Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P<sub>1</sub>)
Journal of Medicinal Chemistry 2016.0
Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease
Bioorganic &amp; Medicinal Chemistry Letters 2012.0
Spiro-1-benzofuranpiperidinylalkanoic acids as a novel and selective sphingosine S1P5 receptor agonist chemotype
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
Discovery of Potent 3,5-Diphenyl-1,2,4-oxadiazole Sphingosine-1-phosphate-1 (S1P<sub>1</sub>) Receptor Agonists with Exceptional Selectivity against S1P<sub>2</sub> and S1P<sub>3</sub>
Journal of Medicinal Chemistry 2005.0
A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists
Journal of Medicinal Chemistry 2004.0
Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity
Journal of Medicinal Chemistry 2015.0
Novel S1P<sub>1</sub> Receptor Agonists – Part 1: From Pyrazoles to Thiophenes
Journal of Medicinal Chemistry 2013.0